Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Faezeh, Hosseinzadeh"'
Autor:
Faezeh Hosseinzadeh, Javad Verdi, Jafar Ai, Saieh Hajighasemlou, Iman Seyhoun, Frzad Parvizpour, Fatemeh Hosseinzadeh, Abolfazl Iranikhah, Sadegh Shirian
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background High prevalence of hepatocellular carcinoma (HCC) and typically poor prognosis of this disease that lead to late stage diagnosis when potentially curative therapies are least effective; therefore, development of an effective and s
Externí odkaz:
https://doaj.org/article/ef945498f9384087bc8af1adf1550aca
Autor:
Faezeh Hosseinzadeh, Jafar Ai, Abbas Hajifathali, Samad Muhammadnejad, Somayeh Ebrahimi-Barough, Iman Seyhoun, Tahereh Komeili Movahed, Sadegh Shirian, Fatemeh Hosseinzadeh, Sajjad Ahmadpour, Mohammadreza Alijani, Javad Verdi
Publikováno v:
Pharmacological Reports. 74:379-391
Natural killer cells (NKC) and Sorafenib (Sor) are two important agents for the treatment of hepatocellular carcinoma (HCC). Over the past decade, the interaction of Sor and NKC against HCC has been widely challenging. This study aimed to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f753854ce3024412daa39a4ede33ce81
https://doi.org/10.1007/s43440-021-00335-y
https://doi.org/10.1007/s43440-021-00335-y
Autor:
Faezeh Hosseinzadeh, Iman Seyhoun, Jafar Ai, Benyamin Parseh, Zeinab Ghazvinian, Javad Verdi, Shahrokh Abdolahi, Milad Mirmoghtadaei, Mahdi Shadnoush, Seyed Moein Seyhoun, Saieh Hajighasemlou
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Objective: Hepatocellular carcinoma (HCC) is the most common liver malignancy. Sorafenib is the first-line systemic treatment for advanced HCCs. However, due to safety concerns, researchers are now looking for ways to boost the efficacy of the medica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845320b8fe07d81b930de687182f86af
https://doi.org/10.31557/apjcp.2019.20.1.263
https://doi.org/10.31557/apjcp.2019.20.1.263
Autor:
Javad Verdi, Iman Seyhoun, Somayeh Ebrahimi-Barough, Abbas Hajifathali, Mahdi Shadnoush, Fatemeh Hosseinzadeh, Samad Muhammadnejad, Farnaz Dabiri Oskouei, Faezeh Hosseinzadeh, Jafar Ai
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: one of the promising approaches for treatment of some cancers is adoptive cell therapy using natural killer (NK) cells. Various methods have been investigated for ex vivo expansion of NK cells in large-scale, but most of them involved can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fa58e0b1e0f107959ea92db43d4193
http://europepmc.org/articles/PMC7173374
http://europepmc.org/articles/PMC7173374
Autor:
Yousef, Rasmi, Shima, Hatamkhani, Roya, Naderi, Ameneh, Shokati, Vajiheh, Nayeb Zadeh, Faezeh, Hosseinzadeh, Yeganeh, Farnamian, Ladan, Jalali
Publikováno v:
Acta Histochemica. 124:151908
Cytokine storms and extra-activated cytokine signaling pathways can lead to severe tissue damage and patient death. Activation of inflammatory signaling pathways during Cytokine storms are an important factor in the development of acute respiratory s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49131f6aea772ff0ceb2c784bd5825a
https://doi.org/10.1016/j.acthis.2022.151908
https://doi.org/10.1016/j.acthis.2022.151908
Publikováno v:
PLoS ONE, Vol 7, Iss 12 (2012)
[This corrects the article DOI: 10.1371/journal.pone.0040017.].
Externí odkaz:
https://doaj.org/article/2fd132e5511743018e97a999488b6948
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40017 (2012)
Rapid distinction between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) tumors is very important in diagnosis of this disease. Furthermore sequence-derived structural and physicochemical descriptors are very useful for machine
Externí odkaz:
https://doaj.org/article/dbd86c97cb284cd7809c2218347120d1
Autor:
Milad Mirmoghtadaei, Faezeh Hosseinzadeh, Jafar Ai, Saieh Hajighasemlou, Ali Akbar Alizadeh, Iman Seyhoun, Mohsen Nikbakht, Javad Verdi, Seyed Moein Seyhoun, Samad Muhammadnejad
Publikováno v:
Journal of Cellular Physiology. 234:9495-9503
Aim Hepatocellular carcinoma (HCC) is the most common liver malignancy and the second leading cause of cancer-related deaths in the world. Sorafenib is the first-line treatment of HCC. Although sorafenib has positive effects on the survival of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::addb1cdc24cb991b7489649ca91c563f
https://doi.org/10.1002/jcp.27637
https://doi.org/10.1002/jcp.27637
Autor:
Saieh, Hajighasemlou, Saeedreza, Pakzad, Jafar, Ai, Samad, Muhammadnejad, Milad, Mirmoghtadaei, Faezeh, Hosseinzadeh, Safoora, Gharibzadeh, Amir, Kamali, Akbar, Ahmadi, Javad, Verdi
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the third leading cause of cancer-related death. sorafenib is used as a standard therapy to treat HCC. mesenchymal stromal cells (MSCs) have also been used to suppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9687fac0ae534c8566a2d12d32ceda7
https://pubmed.ncbi.nlm.nih.gov/29936790
https://pubmed.ncbi.nlm.nih.gov/29936790
Autor:
Fatemeh Hosseinzadeh, Faezeh Hosseinzadeh, Jafar Ai, Saieh Hajighasemlou, Abolfazl Iranikhah, Iman Seyhoun, Javad Verdi, Sadegh Shirian, Frzad Parvizpour
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 18, Iss 1, Pp 1-12 (2018)
Cancer Cell International, Vol 18, Iss 1, Pp 1-12 (2018)
Background High prevalence of hepatocellular carcinoma (HCC) and typically poor prognosis of this disease that lead to late stage diagnosis when potentially curative therapies are least effective; therefore, development of an effective and systematic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22501c6460b819470aaf1b2528cfd0eb
https://pubmed.ncbi.nlm.nih.gov/30214375
https://pubmed.ncbi.nlm.nih.gov/30214375